Outlook Therapeutics (OTLK) Earnings Date, Estimates & Call Transcripts $6.27 -0.20 (-3.09%) (As of 11/12/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Outlook Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateDec. 27EstimatedActual EPS (Aug. 14) -$0.83 Beat By $0.23 Consensus EPS (Aug. 14) -$1.06 Outlook Therapeutics issued Q3 2024 earnings on August 14, 2024, reporting an EPS of -$0.83, which beat analysts' consensus estimates of -$1.06 by $0.23. With a trailing EPS of -$10.70, Outlook Therapeutics' earnings are expected to grow next year, from ($3.84) to ($2.21) per share. OTLK Upcoming EarningsOutlook Therapeutics' next earnings date is estimated for Friday, December 27, 2024, based off prior year's reporting schedules. Get Outlook Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Outlook Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOTLK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OTLK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Outlook Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243-$0.05-$0.04-$0.05Q2 20243-$1.28-$0.42-$0.88Q3 20243-$1.09-$0.64-$0.86Q4 20243-$0.89-$0.76-$0.84FY 202412-$3.31-$1.86-$2.62Q1 20251-$0.99-$0.99-$0.99Q2 20251-$0.58-$0.58-$0.58Q3 20251-$0.43-$0.43-$0.43Q4 20251-$0.24-$0.24-$0.24FY 20254($2.24)($2.24)($2.24) Outlook Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 12/27/2024(Estimated)------- 8/14/2024Q3 2024-$1.06-$0.83+$0.23-$0.77--5/15/2024Q2 2024-$0.88-$1.55 -$0.67$4.91-- 2/14/2024Q1 2024-$1.00-$0.80+$0.20-$0.04-- 12/22/2023Q4 2023-$1.00-$1.00--$0.05-- 8/14/2023Q3 2023-$0.80-$1.60 -$0.80-$0.08-- 5/15/2023Q2 2023-$1.20-$0.60+$0.60-$0.03-- Get the Latest News and Ratings for OTLK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Outlook Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/14/2023Q1 2023-$0.80-$1.60 -$0.80-$0.08-- Outlook Therapeutics Earnings - Frequently Asked Questions When is Outlook Therapeutics's earnings date? Outlook Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, December 27th, 2024 based off last year's report dates. Learn more on OTLK's earnings history. Did Outlook Therapeutics beat their earnings estimates last quarter? In the previous quarter, Outlook Therapeutics (NASDAQ:OTLK) reported ($0.83) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.06) by $0.23. Learn more on analysts' earnings estimate vs. OTLK's actual earnings. How much profit does Outlook Therapeutics generate each year? Outlook Therapeutics (NASDAQ:OTLK) has a recorded net income of -$58.98 million. OTLK has generated -$10.70 earnings per share over the last four quarters. What is Outlook Therapeutics's EPS forecast for next year? Outlook Therapeutics's earnings are expected to grow from ($3.84) per share to ($2.21) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Coherus BioSciences Earnings Champions Oncology Earnings Protara Therapeutics Earnings Acelyrin Earnings Corvus Pharmaceuticals Earnings Nuvation Bio Earnings Q32 Bio Earnings Mereo BioPharma Group Earnings Monte Rosa Therapeutics Earnings Alumis Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here This page (NASDAQ:OTLK) was last updated on 11/12/2024 by MarketBeat.com Staff From Our PartnersTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | SponsoredCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredTrump’s Back, but DC’s Coming for Your Money!Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored6-Figure Target for BTC by 2025According to Steven Lubka, head of a private equity firm with over $250M in assets under management, "Bitcoin ...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCritical warning from the mountains of CarolinaNvidia CEO Jensen Huang says Big Tech will spend over $1 trillion on data centers. And that still might not...Weiss Ratings | SponsoredCrypto’s FINAL Wealth MomentBitcoin’s final bull market is here. If you missed out on the gains in 2017, or 2021… 2025 stands to be jus...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Outlook Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Outlook Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
